Search Results

The Relationship Between the Energization of Moon‐Originating Ions and Terrain Type on the Lunar Surface.

• Authors : Lee, Jae‐Hee¹ (AUTHOR); Kim, Khan‐Hyuk¹ (AUTHOR) ; Baek, Seul‐Min² (AUTHOR)

Subjects: Zenith distance; Ions; Ion energy

• Source: Journal of Geophysical Research. Space Physics. Mar2024, Vol. 129 Issue 3, p1-13. 13p.

Record details

Long‐term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post‐treatment.

• Authors : Symington, Emily; Rangarajan, Savita; Lester, Will

Subjects: GENETIC transformation; TREATMENT effectiveness; BLOOD coagulation factor VIII antibodies

• Source: Haemophilia; Mar2024, Vol. 30 Issue 2, p320-330, 11p

Record details

Safety and efficacy of damoctocog alfa pegol prophylaxis in patients with severe haemophilia A: Results of an interventional, post‐marketing study.

• Authors : Holme, Pål André; Poulsen, Lone Hvitfeldt; Tueckmantel, Claudia

Subjects: HEMOPHILIACS; BLOOD coagulation factor VIII antibodies; OLDER patientsBETHESDA (Md.)

• Source: Haemophilia; Mar2024, Vol. 30 Issue 2, p388-394, 7p

Record details

Acquired haemophilia A in paediatric patients: A retrospective French cohort of eight cases.

• Authors : Mouthon, Paul; Guy, Alexandre; d'Oiron, Roseline

Subjects: CHILD patients; HEMOPHILIA; HEMORRHAGIC diseasesBETHESDA (Md.); FRANCE

• Source: British Journal of Haematology; Feb2024, Vol. 204 Issue 2, p606-611, 6p

Record details

Quantitative transcriptome‐based analysis predicts a combination therapy for severe haemophilia B: A case report.

• Authors : Zhang, Jundong¹ (AUTHOR); Chen, Haoran² (AUTHOR); Shi, Lei³ (AUTHOR)

Subjects: *BLOOD coagulation factor VIII; *HEMOPHILIA; *QUANTITATIVE research

• Source: British Journal of Haematology. Mar2024, Vol. 204 Issue 3, p1105-1108. 4p.

Record details

The effects of time and temperature on the in vitro stability of emicizumab in blood samples: Implications for laboratory and clinical practices.

• Authors : Bentounes, Nûn K.¹ (AUTHOR); Lasne, Dominique^1,2 (AUTHOR); Habay, Capucine¹ (AUTHOR)

Subjects: *EMICIZUMAB; *BLOOD coagulation factor VIII antibodies; *BLOOD sampling

• Source: Haemophilia. Mar2024, Vol. 30 Issue 2, p554-557. 4p.

Record details

Publication Only Abstracts.

Subjects: *BLOOD coagulation factor VIII; *HEMOPHILIACS; *BLOOD coagulation factors

• Source: Haemophilia. 2024 Suppl 1, Vol. 30, p189-190. 2p.

Record details

A post hoc analysis of PROTECT VIII kids assessing long‐term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia A.

• Authors : Ahuja, Sanjay; Biss, Tina; Maas Enriquez, Monika

Subjects: BLOOD coagulation factor VIII antibodies; HEMOPHILIA; TEENAGERS

• Source: European Journal of Haematology; May2024, Vol. 112 Issue 5, p756-764, 9p

Record details

Emicizumab prophylaxis in infants: Single‐centre experience.

• Authors : Levy‐Mendelovich, Sarina; Greenberg‐kushnir, Noa; Budnik, Ivan

Subjects: EMICIZUMAB; BLOOD coagulation factor VIII antibodies; INFANTS

• Source: British Journal of Haematology; Apr2024, Vol. 204 Issue 4, p1375-1382, 8p

Record details

A Generative and Causal Pharmacokinetic Model for Factor VIII in Hemophilia A: A Machine Learning Framework for Continuous Model Refinement.

• Authors : Janssen, Alexander; Smalbil, Louk; Bennis, Frank C.

Subjects: HEMOPHILIA; MACHINE learning; CAUSAL models

• Source: Clinical Pharmacology & Therapeutics; Apr2024, Vol. 115 Issue 4, p881-889, 9p

Record details